论文信息 - Hypertension pulmonaire: Pulmonary hypertension - 字舞流文

Hypertension pulmonaire: Pulmonary hypertension

D. Montani | A. Boucly

[1] M. Humbert,et al. The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension , 2014, Therapeutic advances in respiratory disease.

[2] W. Chung,et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. , 2014, Chest.

[3] H. Ghofrani,et al. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. , 2010, American journal of respiratory and critical care medicine.

[4] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[5] M. Humbert,et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[6] A. Nicholson,et al. Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.

[7] W. Seeger,et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.